Corporate Controller – Soleno

Developing novel therapeutics for the treatment of rare diseases.

Pages

News and Events

DCCR ‘Worked Across the Board’ in PWS Trial, But Results Are Less Clear

Soleno Therapeutics Receives Orphan Drug Designation from FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a

Contact Us

  • 203 Redwood Shores Parkway
  • Suite 500
  • Redwood City, CA 94065